Table 4.
Variable | HR (95% CI) | p-Value |
---|---|---|
PEG-IFN-β-1a (vs sc. IFN-β-1a) | 0.256 (0.096–0.681) | 0.006 |
Treatment duration (months) | 0.993 (0.964–1.022) | 0.619 |
Age at Tx-start (years) | 0.998 (0.961–1.037) | 0.934 |
Number of previous therapies | 0.649 (0.300–1.403) | 0.272 |
Leukocytes baseline (leukocytes/nl) | 0.580 (0.428–0.784) | <0.001 |
Significant p values are highlighted in bold.
CI, confidence interval; HR, hazard ratio; IFN-β, interferon-beta; Tx, drug treatment.